Article

Agreement Between Drugs-to-Avoid Criteria and Expert Assessments of Problematic Prescribing—Invited Commentary

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Archives of internal medicine (Impact Factor: 17.33). 08/2009; 169(14):1332-4. DOI: 10.1001/archinternmed.2009.180
Source: PubMed
Download full-text

Full-text

Available from: Budnitz Daniel, Jan 30, 2014